SAMSUNG BIOLOGICS TO ACQUIRE SWISS-BASED CDMO FIRM FOR 2.7 TLN WON - YONHAP
Major acquisition of Swiss CDMO for 2.7 trillion won signals significant industry consolidation.
What changed
Major acquisition of Swiss CDMO for 2.7 trillion won signals significant industry consolidation.
Why it matters
Major acquisition of Swiss CDMO for 2.7 trillion won signals significant industry consolidation. — impact context not separately stored; see What changed.
← Dashboard
Jul 20, 2026 02:34 AM ET